438 related articles for article (PubMed ID: 34420245)
1. Is there an association between zinc and COVID-19-associated mucormycosis? Results of an experimental and clinical study.
Muthu V; Kumar M; Paul RA; Zohmangaihi D; Choudhary H; Rudramurthy SM; Panda NK; Pannu AK; Sharma N; Sharma S; Chakrabarti A; Agarwal R
Mycoses; 2021 Oct; 64(10):1291-1297. PubMed ID: 34420245
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of environmental Mucorales contamination in and around the residence of COVID-19-associated mucormycosis patients.
Ghosh AK; Singh R; Reddy S; Singh S; Rudramurthy SM; Kaur H; Choudhary H; Chakrabarti A
Front Cell Infect Microbiol; 2022; 12():953750. PubMed ID: 36118044
[TBL] [Abstract][Full Text] [Related]
3. Can low-dose radiation therapy reduce the risk of mucormycosis in COVID-19 patients?
Sharma DN; Welsh J; Kumar R
J Cancer Res Ther; 2021; 17(6):1294-1296. PubMed ID: 34916356
[No Abstract] [Full Text] [Related]
4. Features and evaluation of mucormycosis in COVID-19 patients from two referral hospitals in Iran.
Fakhim H; Irani S; Yassin Z; Badali H; Nasri E; Nasoori Y; Samimiardestani S; Mohebbi S; Mohammadi Ardehali M; Alizadeh Pahlavan P; Firouzifar M; Tajdini A; Ahadi S; Vaezi A
J Mycol Med; 2024 Jun; 34(2):101480. PubMed ID: 38744060
[TBL] [Abstract][Full Text] [Related]
5. Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India.
Mishra Y; Prashar M; Sharma D; Akash ; Kumar VP; Tilak TVSVGK
Diabetes Metab Syndr; 2021; 15(4):102196. PubMed ID: 34246939
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
Wasiq M; K R; Gn A
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
[TBL] [Abstract][Full Text] [Related]
7. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
Rao C; R M
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
[TBL] [Abstract][Full Text] [Related]
8. Serum glucose-regulated protein 78 (GRP78) levels in COVID-19-associated mucormycosis: results of a case-control study.
Muthu V; Dhaliwal M; Sharma A; Nair D; Kumar HM; Rudramurthy SM; Sehgal IS; Choudhary H; Panda N; Chakrabarti A; Agarwal R
Mycopathologia; 2022 Aug; 187(4):355-362. PubMed ID: 35727491
[TBL] [Abstract][Full Text] [Related]
9. Could cattle dung burning have contributed to the epidemic of COVID-19-associated mucormycosis in India? Results of an experimental aero-mycological study.
Kathirvel S; Muthu V; Rudramurthy SM; Kaur H; Chakrabarti A; Agarwal R
Mycoses; 2022 Nov; 65(11):1024-1029. PubMed ID: 35726395
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
[TBL] [Abstract][Full Text] [Related]
11. Multicenter Case-Control Study of COVID-19-Associated Mucormycosis Outbreak, India.
Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur VK; Maturu VN; Srinivasan A; Sethuraman N; Sibia RPS; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Sistla SK; Padaki PA; Ramar D; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
Emerg Infect Dis; 2023 Jan; 29(1):8-19. PubMed ID: 36573628
[TBL] [Abstract][Full Text] [Related]
12. Serum iron indices in COVID-19-associated mucormycosis: A case-control study.
Kumar H M; Sharma P; Rudramurthy SM; Sehgal IS; Prasad KT; Pannu AK; Das R; Panda NK; Sharma N; Chakrabarti A; Agarwal R; Muthu V
Mycoses; 2022 Jan; 65(1):120-127. PubMed ID: 34743358
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-associated Mucormycosis: A clinico-epidemiological study.
Chakravarty J; Gupta MK; Tilak R; Kumar R; Maurya RP; Kumar N; Aggarwal SK; S S; Sharma NK; Dhiman NK; Chaubey M; Singh V; Verma A; Banerjee T; Agrawal NK; Prasad RS
J Diabetes Complications; 2022 Sep; 36(9):108284. PubMed ID: 35987108
[TBL] [Abstract][Full Text] [Related]
14. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment.
Prakash H; Ghosh AK; Rudramurthy SM; Singh P; Xess I; Savio J; Pamidimukkala U; Jillwin J; Varma S; Das A; Panda NK; Singh S; Bal A; Chakrabarti A
Med Mycol; 2019 Jun; 57(4):395-402. PubMed ID: 30085158
[TBL] [Abstract][Full Text] [Related]
15. Cerebrovascular Involvement in Mucormycosis in COVID-19 Pandemic.
Kulkarni R; Pujari SS; Gupta D; Ojha P; Dhamne M; Bolegave V; Dhonde P; Soni A; Adwani S; Diwan A; Duberkar D; Batra D; Deshpande R; Aurangabadkar K; Palasdeokar N
J Stroke Cerebrovasc Dis; 2022 Feb; 31(2):106231. PubMed ID: 34890962
[TBL] [Abstract][Full Text] [Related]
16. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.
Muthu V; Rudramurthy SM; Chakrabarti A; Agarwal R
Mycopathologia; 2021 Dec; 186(6):739-754. PubMed ID: 34414555
[TBL] [Abstract][Full Text] [Related]
18. Microbiology Profile of COVID-19-Associated Rhino-Orbital Mucormycosis Pathogens in South India.
Sheba E; Sharma S; Kumar Mishra D; Vivek Dave T; Ganguly Kapoor A; Joseph J
Am J Trop Med Hyg; 2023 Feb; 108(2):377-383. PubMed ID: 36572009
[TBL] [Abstract][Full Text] [Related]
19. COVID-19-associated-mucormycosis: possible role of free iron uptake and immunosuppression.
Tabassum T; Araf Y; Moin AT; Rahaman TI; Hosen MJ
Mol Biol Rep; 2022 Jan; 49(1):747-754. PubMed ID: 34709573
[TBL] [Abstract][Full Text] [Related]
20. Multimodal analysis of the COVID-19-associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors.
Chowdhary A; Gupta N; Wurster S; Kumar R; Mohabir JT; Tatavarthy S; Mittal V; Rani P; Barman P; Sachdeva N; Singh A; Sharma B; Jiang Y; Cuomo CA; Kontoyiannis DP
Mycoses; 2023 Jun; 66(6):515-526. PubMed ID: 36790120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
